There was no statistically significant association between CD133 expression and age, gender, primary tumor location, presence of distant metastasis, histologic grade, tumor size, presence of lymph node metastasis and UICC staging. This evidence concerns the gene PROM1 and metastatic malignant neoplasm in the lymph nodes.